Application YC di WonderTx
San Francisco
WonderTx ha partecipato a Y Combinator nel batch Summer 2026 come azienda Healthcare. Sotto: cosa fa l'azienda, chi l'ha fondata e la sua application a YC, ricostruita domanda per domanda nel form reale di YC.
- Batch YC
- Summer 2026
- Settore
- HealthcareTherapeutics
- Luogo
- San Francisco
- Dimensione team
- 3
- Stato
- Active
- Lanciata
- 2026
Founder
Abraham HeifetsFounder/CEO
Cosa fa WonderTx
We’re an AI-native biotech, working on replacing needles with pills. Many drugs, like insulin or Ozempic, are wonderful except you have to inject them. We discover new molecules that you can take as a pill instead. Because the pills operate on biology which has been shown to be effective in people, rather than merely in animal models of disease, we avoid what has historically been the single biggest risk in drug discovery. This should dramatically increase our probability of success. There’s $200B of treatable diseases and validated human biology without a pill because discovery programs lack a tractable chemical starting point. This is a zero-shot inference problem, because these targets have no training data, so LLMs and other historical interpolative AI approaches are insufficient. Instead, we are building our own extrapolative frontier models that reason beyond their training data. Most critically, we have repeatedly validated our platform on both our own and partner programs. On 4 biologically- and structurally-diverse targets where we had zero training data, we successfully picked binders that were validated experimentally, with confirmation ranging from primary screen hits to crystallographic structures.
Application YC di WonderTx, ricostruita
Domanda per Y Combinator
WonderTx, batch Summer 2026. Le vere domande del form, risposte da dati pubblici.
- Founders2
- Company7
- Progress7
- Idea4
- Equity3
- Curious2
- Batch Preference1
Company
WonderTx
AI discovers pills to replace injectable drugs
We are building an AI-native biotech platform for oral drug discovery. Our tech designs new molecules that let you take, for example, insulin or Ozempic as a pill instead of a shot. Our models are trained to reason on targets that have worked in real humans, not just in animal models, removing the main risk in drug discovery. Drug discovery teams use our molecules to pursue first-in-class oral drugs for validated biology where there was no tractable starting point before.
We are based in San Francisco, CA, USA, and work remotely. After YC, we will remain based in San Francisco and remote.
San Francisco has a deep biotech and AI ecosystem, which helps on both the research and fundraising side. Our work is computational and experimental, so we work distributed, but physically close to the Bay Area network.
21 risposte in più nell'application completa
Founders, Progress, Idea, Equity, Curious, Batch Preference sono nella versione completa. Crea un account gratuito per aprirla in YC Insights, accanto a ogni altro batch YC.
Domande Frequenti
Questa è l'application YC reale di WonderTx?
No. Y Combinator mantiene private le application inviate. Questa è una ricostruzione: le domande del form YC reale, a cui si è risposto usando i dati pubblici di WonderTx (note di lancio, background dei founder, descrizione del prodotto). Mostra come un'azienda come WonderTx si presenterebbe a YC, non il testo che hanno inviato.
A quale batch YC apparteneva WonderTx?
WonderTx apparteneva al batch Summer 2026 di Y Combinator.
Chi ha fondato WonderTx?
WonderTx è stato fondato da Abraham Heifets.
Cosa fa WonderTx?
Extrapolative AI to unlock First-in-Class drugs
Come leggo la ricostruzione completa della application?
Crea un account Round Funded gratuito. La versione completa di 26 risposte della application di WonderTx, e di ogni altro batch YC, è in YC Insights.
Più startup YC come WonderTx
